Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 1 of 62

AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking AmpioPharmaceuticalsBevyofRepositioned
1 2011.08.16 Cassano,Vincent VFC'sStockHouse Lavos AMPE Y Y
Alpha ProductsCouldMakeaSplashinHealthCare

Seeking BiotechonTheVergeAmpioPharmaceuticals
2 2011.08.23 Cassano,Vincent VFC'sStockHouse Lavos AMPE Y Y
Alpha BolstersItsManagement

Seeking AmpioReboundsAsStudyResultsPublished
3 2011.08.31 Cassano,Vincent VFC'sStockHouse Lavos AMPE Y N
Alpha inEurope

AmpioPharmaceuticals:Catalysts/Recent
Seeking
4 2011.09.29 Cassano,Vincent VFC'sStockHouse Lavos AMPE SlideMayHaveOpenedUpABuying Y N
Alpha
Opportunity

Seeking AmpiosReboundGoesHandInHandWith
5 2011.10.17 Cassano,Vincent VFC'sStockHouse Lavos AMPE Y N
Alpha PipelineProgress

Seeking AnotherRoundofMilestoneNewsSolidifies
6 2011.10.26 Cassano,Vincent VFC'sStockHouse Lavos AMPE Y N
Alpha AmpiosPipelinePotential

Seeking ImmunoCellularTherapeutics'CancerStem
7 2011.11.08 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Y N
Alpha CellDrugGarneringMuchAttention

Seeking 3CancerImmunotherapyBiotechswith
8 2011.11.16 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Y N
Alpha Catalystsfor2012

1
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 2 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking StockstoWatchasVolatilityAboundsin
9 2011.11.16 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo LPTN Y N
Alpha Europe

Seeking LipidSignalingCouldShakeUpBiotechin2012
10 2011.11.22 Ramey,Stephen Chemistfrog Lavos/Lidingo LPTN Y N
Alpha WithPendingLpathandPeregrineTrialData

Seeking LipidSignaling:TheNextEvolutionaryStepIn
11 2011.12.07 Ramey,Stephen Chemistfrog Lavos/Lidingo LPTN Y N
Alpha WetAMDTreatment?

Seeking LowerR&DBudgetsForBigPharmaCreatingA
12 2011.12.12 Writer2 N/A Lavos/Lidingo LPTN Y N
Alpha BrighterFutureForTheRightBiotechs

Seeking
13 2012.01.10 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo LPTN StocksToWatchThisWeek Y N
Alpha

Seeking
14 2012.01.11 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE,LPTN TopOfTheClassBiotechsFor2012 Y N
Alpha

Seeking PharmaLeadersEmerginginImmunotherapy
15 2012.01.16 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Y N
Alpha ApproachtoFightingGlioblastoma

Seeking AnotherRevivalCouldBeInStorefor
16 2012.01.18 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC Y N
Alpha ImmunoCellularTherapeutics

2
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 3 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
17 2012.01.19 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC BiopharmaStocksToWatchThisWeek Y N
Alpha

Seeking ImmunotherapyCancerTrialswithKeyData
18 2012.01.25 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE Y N
Alpha Duein2012

Seeking
19 2012.01.30 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC StocksToWatchWeekofJan.30 Y N
Alpha

Seeking VerastemIPOValidatesInvestorInterestin
20 2012.01.30 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Y N
Alpha CancerStemCellApproach

Seeking ImmunoCellular:PipelinePotentialand
21 2012.01.31 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC Y N
Alpha InstitutionalInterestFuelRebound

Seeking IllogicalBiotechValuationsCreateValueand
22 2012.02.01 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha ValueTraps

Seeking
23 2012.02.02 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC 5PharmaceuticalsOnTheMove Y N
Alpha

Seeking
24 2012.02.06 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC StockstoWatchWeekofFeb.6 Y N
Alpha

3
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 4 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking ImmunoCellularandCancerTreatment'sNext
25 2012.02.08 Writer2 N/A Lavos/Lidingo GALE,IMUC Y N
Alpha Frontier

Seeking 10BiotechStockswithBigPotentialUpsidein
26 2012.02.13 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha 2012:PartTwo

Seeking
27 2012.02.14 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC WeeklyStockWatch:Feb.13Edition Y N
Alpha

Seeking StockWatch:Immunocellular'sPushToward
28 2012.02.14 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC Y N
Alpha TwoDollars

Seeking
29 2012.02.15 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC ImmunocellularAgainPushingto$2 Y N
Alpha

Seeking 10BiotechStockswithBigPotentialUpsidein
30 2012.02.16 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha 2012:PartIII

Seeking ARoadmapforImmunotherapySuccessin
31 2012.02.21 Writer2 N/A Lavos/Lidingo IMUC Y N
Alpha Oncology

Seeking
32 2012.02.22 Nichols,Brian N/A Lavos/Lidingo IMUC BuyBiotechinPhaseIIfortheBestUpside Y N
Alpha

4
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 5 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking Dendreon'sWoesMasktheExciting
33 2012.03.01 Nichols,Brian N/A Lavos/Lidingo GALE,IMUC Y N
Alpha OpportunitiesinImmunotherapyCompanies

Seeking
34 2012.03.04 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC WeeklyStockWatch:Feb27March2 Y N
Alpha

Seeking ImmunocellularTherapeutics:Pending
35 2012.03.05 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC Y N
Alpha CatalystsCouldSparkSharePriceRun

Seeking BigPharma'sGrowingAppetiteforCancer
36 2012.03.06 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Y N
Alpha StemCellBiotechs

Seeking ImmunocellularTouches$3onContinued
37 2012.03.07 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC Y N
Alpha Speculation

Seeking BreastCancerImmunotherapy:ANewHope
38 2012.03.09 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE Y N
Alpha intheFight

Seeking
39 2012.03.13 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC WeeklyStockWatch:March1216 Y N
Alpha

Seeking UpgradesLeadtoOptimisminCancerStem
40 2012.03.13 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha CellTherapy

5
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 6 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking GalenaLooksUndervaluedConsideringCancer
41 2012.03.13 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo GALE Y N
Alpha TherapyResults

Seeking
42 2012.03.19 Lidingo A.JohnHodge Lavos/Lidingo GALE,IMUC SmallCapBiotechStocksTradingHigher Y N
Alpha

Seeking
43 2012.03.21 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC StockstoWatch:WeekofMarch1923 Y N
Alpha

Seeking
44 2012.03.21 Nichols,Brian N/A Lavos/Lidingo GALE GalenaBiopharmaPreparingfora3DayRally? Y N
Alpha

Seeking GalenaBiopharma'sPatentCreatesBoth
45 2012.03.21 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha ImmediateandLongTermUpside

Seeking ImmunocellularTherapeuticsPatent
46 2012.03.22 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha AcquisitionParadigmShift

ImmunocellularTherapeutics:CementingIts
Seeking
47 2012.03.26 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC PlaceasaMajorPlayerinCancer Y N
Alpha
Immunotherapy

Seeking
48 2012.03.26 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo GALE,IMUC StockstoWatch:WeekofMarch2630 Y N
Alpha

6
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 7 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
49 2012.03.26 Lidingo TheSwissTrader Lavos/Lidingo GALE GalenaBiopharma:AnInvestor'sOverview Y N
Alpha

Seeking
50 2012.03.27 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC WeeklyStockWatch:March2620[sic] Y N
Alpha

ImmunoCellular'sIntellectualProperty
51 2012.03.28 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Benzinga Y N
SteadilyIncreases

Seeking ImmunoCellularTherapeutics'Growing
52 2012.03.28 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Y N
Alpha IntellectionalPropertyGarneringAttention

Seeking GalenaBiopharma:RiskMitigatedAfter
53 2012.04.05 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo GALE Y N
Alpha Financing

Seeking
54 2012.04.09 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC WeeklyStockWatch:April913 Y N
Alpha

Seeking BreakingtheMoldofOncologyDrug
55 2012.04.10 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha Development

Seeking ImmunocellularTherapeuticsMayBeImmune
56 2012.04.11 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC Y N
Alpha toaBroadMarketDownturn

7
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 8 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
57 2012.04.11 Lidingo TheSwissTrader Lavos/Lidingo GALE GalenaandtheRXISpinOff Y N
Alpha

Seeking WhichQ1BiotechMoversCanBuildoff
58 2012.04.12 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha Momentum?PartII

Seeking WhichQ1BiotechMoversCanBuildOff
59 2012.04.12 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha Momentum?

Seeking LongGalenaBiopharma:CreatingaNew
60 2012.04.12 Lidingo Baldwin,Amy Lavos/Lidingo GALE Y N
Alpha BreastCancerTreatmentAlternative

Seeking SuccessfullyProfitingfromDevelopmental
61 2012.04.16 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha Biotech

Seeking PhaseIIITrialBiotechsforInvestment
62 2012.04.17 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE Y N
Alpha Consideration

Seeking
63 2012.04.19 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC StockstoWatchMidWeek:April18 Y N
Alpha

Seeking StemCellResearch:WhichCompaniesWill
64 2012.04.19 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y N
Alpha EmergeAsFrontrunners?

8
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 9 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking WhytheMarketsContinuetoCoalesce
65 2012.04.19 Writer2 N/A Lavos/Lidingo IMUC Y N
Alpha AroundNewApproachestoTreatingCancer

66 2012.04.21 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Benzinga StemCellBiotechs:AFrontrunnerEmerges? Y N

Seeking
67 2012.04.23 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC WeeklyStockWatch:April2327 Y N
Alpha

Seeking Neostem:InvestinginthePotentialSuccessof
68 2012.04.23 Nichols,Brian N/A Lavos/Lidingo NBS Y N
Alpha CellTherapy

Market NeostemInc.(NBS)isPoisedforGrowthin
69 2012.04.23 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y N
Playground 2012

Seeking GalenaBiopharma:HowLongCanBigPharma
70 2012.04.23 Lidingo Baldwin,Amy Lavos/Lidingo GALE Y N
Alpha Wait?

MultipleAntigenTargetingCouldMeana
71 2012.04.24 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE,IMUC Benzinga MultipleMarketingforTheseImmunotherapy Y N
Drugs

Seeking MultipleAntigenTargetingCouldIndicateBig
72 2012.04.25 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE,IMUC Y N
Alpha PotentialforImmunotherapyDrugs

9
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 10 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
73 2012.04.27 Writer5 DutchTrader Lavos/Lidingo NBS NeoStem'sComebackInTheMaking Y N
Alpha

Seeking
74 2012.04.29 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC WeeklyStockWatch:April30May4 Y N
Alpha

Seeking ImmunoCellularTherapeuticsandtheBenefits
75 2012.04.30 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha ofaLargeExchange

Seeking ImmunocellularTherapeutics:AnyPullback
76 2012.05.01 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC Y N
Alpha MayMeanOpportunity

Seeking InterviewingMarkAhn:theTruthbehind
77 2012.05.02 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha Neuvax

Seeking FindinganOncologyPlayerThatWillChange
78 2012.05.02 Lidingo TheSwissTrader Lavos/Lidingo IMUC Y N
Alpha theRulesoftheGame

Seeking
79 2012.05.07 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo IMUC StockstoWatch:WeekofMay7,2012 Y N
Alpha

Seeking StemCellBiotechsReport2011Yearin
80 2012.05.07 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y N
Alpha Review:Part1

10
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 11 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking StemCellBiotechsReport2011Yearin
81 2012.05.07 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y N
Alpha Review:PartII

Seeking TargetedChemotherapy:ThePerfectBalance
82 2012.05.07 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y N
Alpha BetweenSafetyandEfficacy?

Seeking PreASCOInterviewwithImmunoCellular
83 2012.05.10 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha TherapeuticsCEODr.Singh

Seeking
84 2012.05.10 Lidingo TheSwissTrader Lavos/Lidingo NBS 5ReasonstoBuyNeoStemand2Catalysts Y N
Alpha

Seeking OncosecMedical:DevelopingaNew
85 2012.05.10 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo ONCS Y N
Alpha ApproachinCancerTreatments

Seeking
86 2012.05.14 Nichols,Brian N/A Lavos/Lidingo NBS NeoStem:TrioofCatalysts? Y N
Alpha

Seeking
87 2012.05.15 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE ProvengeandNeuVax:ATaleof2Marvels Y N
Alpha

Seeking PublicOfferingsCreateInvesting
88 2012.05.15 Lidingo TheSwissTrader Lavos/Lidingo NBS,ONCS Y N
Alpha OpportunitiesinBiotechSector

11
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 12 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking Dr.RobinSmithExplainingNeostem:aTrue
89 2012.05.18 Nichols,Brian N/A Lavos/Lidingo NBS Y N
Alpha ValuePlay

Seeking ASCO2012Abstracts:4Hopeful
90 2012.05.18 Lidingo TheSwissTrader Lavos/Lidingo GALE,IMUC Y N
Alpha Overachievers

Seeking GalenaBiopharmaWithNearTermASCO
91 2012.05.21 Lidingo TheSwissTrader Lavos/Lidingo GALE Y N
Alpha Catalyst

Seeking
92 2012.05.21 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo IMUC InterestGrowinginCancerStemCellBiotechs Y N
Alpha

Seeking InvestmentChoicesforMelanomaAwareness
93 2012.05.21 Lidingo Baldwin,Amy Lavos/Lidingo ONCS Y N
Alpha Month

Seeking WeighingtheBenefitsofOsiris'sFirstCell
94 2012.05.23 Lidingo A.JohnHodge Lavos/Lidingo NBS Y N
Alpha TherapyApproval

Seeking AShortInterviewWithGalenaCEODr.Ahnto
95 2012.05.25 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha AddressRecentConcerns

Seeking
96 2012.05.28 Writer5 DutchTrader Lavos/Lidingo NBS NeoStemAChineseTakeoverCandidate? Y N
Alpha

12
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 13 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking ImmunoCellularTherapeutics'Uplistingto
97 2012.05.29 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha NYSECouldImmediatelyOpenManyDoors

Seeking
98 2012.05.30 Lidingo A.JohnHodge Lavos/Lidingo ONCS HyperNovelInvestmentsforTargetingCancer Y N
Alpha

Seeking ImmunoCellularTherapeuticsICT107To
99 2012.06.01 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Y N
Alpha ImpressatASCO2012

Seeking BaxterandNeoStemValidatingEachOther's
100 2012.06.01 Lidingo TheSwissTrader Lavos/Lidingo NBS Y N
Alpha CellTherapies

Seeking 5BiotechStocksthatCouldBeIncludedinthe
101 2012.06.04 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha Russell2000

Seeking AlternativeCancerTherapiesCurrently
102 2012.06.04 Writer5 DutchTrader Lavos/Lidingo ONCS Y N
Alpha OverlookedbyInvestors

Seeking NeoStem:anInvestmentinBothStemCell
103 2012.06.05 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y N
Alpha andImmunotherapy

Seeking ASCOwithUpgrades:CreateCatalystsfor
104 2012.06.05 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo GALE Y N
Alpha Growth

13
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 14 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking RussellIndexAdditionstoCreateUpside
105 2012.06.11 Nichols,Brian N/A Lavos/Lidingo IMUC Y N
Alpha WhileSharesareAcquiredinOpenMarket

Seeking OrphanDrugDesignationBiotechsfor
106 2012.06.12 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y N
Alpha InvestmentConsideration

Seeking
107 2012.06.12 Writer5 DutchTrader Lavos/Lidingo NBS NeoStemandtheChineseHealthcareSector Y N
Alpha

Seeking
108 2012.06.13 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC Dendreon:RoomforImprovement Y N
Alpha

Seeking Galena'sBigDataInsinuatesBigUpside,While
109 2012.06.13 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo GALE Y N
Alpha ValuationPresentsMinimalDownside

Seeking Neostem's$50MillionSaleLiftsRestraints,
110 2012.06.18 Nichols,Brian N/A Lavos/Lidingo NBS Y N
Alpha AllowstheCompanytoThrive

Seeking 4StocksthatCouldTradeHigherinthe
111 2012.06.18 Lidingo Baldwin,Amy Lavos/Lidingo GALE Y N
Alpha ComingWeeks

Seeking
112 2012.06.18 Lidingo TheSwissTrader Lavos/Lidingo IMUC ImmunotherapyComesofAgeatASCO2012 Y N
Alpha

14
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 15 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3SmallCapPharmaswithMajorSecondHalf
113 2012.06.19 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y N
Alpha 2012Catalysts

Seeking RadiationTreatmentsLookPoisedToGrowIn
114 2012.06.19 Lidingo A.JohnHodge Lavos/Lidingo ADMD Y N
Alpha TheImmediateFuture

Seeking 6StocksTradingwithMomentumCanit
115 2012.06.20 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha Continue?

Seeking NeoStem:CorrectingwithMarketLeading
116 2012.06.25 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo NBS Y N
Alpha Gains

Seeking ImmunoCellular:CancerisSmart,ButCouldan
117 2012.06.27 Lidingo A.JohnHodge Lavos/Lidingo IMUC Y N
Alpha ExperimentalCancerVaccineBeSmarter?

Seeking Baxter,NeoStemDuelforNextGenHeart
118 2012.07.03 Lidingo Baldwin,Amy Lavos/Lidingo NBS Y N
Alpha DiseaseStemCellTherapy

Seeking MelanomaTreatmentsLooktoBenefitFrom
119 2012.07.03 Lidingo TheSwissTrader Lavos/Lidingo ONCS Y N
Alpha LargeMarket

Seeking
120 2012.07.04 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC DendriticCellEvolution:InvestmentPotential Y N
Alpha

15
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 16 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking CardiovascularCellTherapiestoPutPressure
121 2012.07.05 Nichols,Brian N/A Lavos/Lidingo NBS Y N
Alpha onU.S.Regulators

Seeking
122 2012.07.08 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo GALE Q1BiotechMoversMakingaComeback Y N
Alpha

Seeking RussellRebalancingLeavesNeoStemTrading
123 2012.07.09 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo NBS Y N
Alpha HighertoReflectGoodNews

Seeking
124 2012.07.11 Ramey,Stephen Chemistfrog Lavos/Lidingo IMUC IntellectualPropertyofaBiotech:AnAnalysis Y N
Alpha

Seeking NeostemContinuestoRallyBehindItsKey
125 2012.07.17 Nichols,Brian N/A Lavos/Lidingo NBS Y N
Alpha Developments

Seeking InvestmentPotentialInElectroporation
126 2012.07.17 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y N
Alpha Companies

Seeking 3InnovativeCancerTreatments...ButWhich
127 2012.07.17 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo IMUC Y N
Alpha IstheBestBet?

NewLegislationSpeedsupFDAApproval
Seeking
128 2012.07.19 Nichols,Brian N/A Lavos/Lidingo IMUC ProcessforImmunocellularTherapeuticsand Y N
Alpha
OtherInnovatingTherapies

16
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 17 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
129 2012.07.19 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo NBS ABigWinforNeoStem Y N
Alpha

ImmunoCellularTherapeutics:Explainingthe
Seeking
130 2012.07.23 Nichols,Brian N/A Lavos/Lidingo IMUC BenefitsofaMultipleAntigenTargeting Y N
Alpha
Approach

Seeking WeekofJuly23rdComprisedofHuge
131 2012.07.23 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y N
Alpha PharmaceuticalCatalysts

Seeking HeavyVolumeMayMeanHeavierProfitsin
132 2012.07.23 Lidingo Baldwin,Amy Lavos/Lidingo NBS Y N
Alpha SmallBiopharmaceuticalStocks

Seeking InvestmentsinRadiotherapyCanPrevent
133 2012.07.24 Ramey,Stephen Chemistfrog Lavos/Lidingo ADMD Y N
Alpha DecayinYourPortfolio

Seeking CancerVaccinesShowPositiveResultsfor
134 2012.07.24 Lidingo Kawabe,Henry Lavos/Lidingo GALE Y N
Alpha BothPatientsandInvestors

Seeking SignificantInvestmentPotentialIntheFast
135 2012.07.26 Lidingo A.JohnHodge Lavos/Lidingo ONCS Y N
Alpha GrowingMetastaticMelanomaMarket

Seeking 5MomentumStocksWithPullbacksThat
136 2012.07.26 Lidingo Baldwin,Amy Lavos/Lidingo IMUC Y N
Alpha CouldBeYourOpportunity

17
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 18 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking Neostem'sPromisingVSELDevelopmentsare
137 2012.07.26 Lidingo TheSwissTrader Lavos/Lidingo NBS Y N
Alpha GoodSignsfortheFutureofCellTherapy

Seeking
138 2012.07.28 Lidingo TheSwissTrader Lavos/Lidingo ONCS SmallCapAdjuvantsforCancerTreatment Y N
Alpha

Seeking AreStemCellsBecomingtheNextBullMarket
139 2012.07.30 Lidingo Baldwin,Amy Lavos/Lidingo NBS Y N
Alpha intheBiotechSpace?

Seeking Radioisotopes:NewHopeUsinganOld
140 2012.08.01 Ramey,Stephen Chemistfrog Lavos/Lidingo ADMD Y N
Alpha Therapy

Seeking DendreonApproachingEndofRoad,While
141 2012.08.01 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo GALE Y N
Alpha OtherImmunotherapiesThrive

Seeking RiskinthePharmaceuticalSector
142 2012.08.02 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y N
Alpha OveremphasizedinthePastWeek

Seeking 3DiverseInvestmentGradePharmaceuticals
143 2012.08.08 French,Chris CrisFrangold Lavos/Lidingo IMUC Y N
Alpha toConsiderToday

Seeking StemCellSectorValidatingItselfwithExciting
144 2012.08.08 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y N
Alpha FirstHalf2012

18
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 19 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3BiotechCompaniestoConsiderforStemCell
145 2012.08.09 French,Chris CrisFrangold Lavos/Lidingo NBS Y N
Alpha Exposure

Seeking RidingtheUpsandDownsAmong
146 2012.08.09 Lidingo A.JohnHodge Lavos/Lidingo ADMD Y N
Alpha PharmaceuticalCompanies

Seeking StemCellTherapyGainingGroundand
147 2012.08.11 Lidingo A.JohnHodge Lavos/Lidingo NBS Y N
Alpha InvestorAttention

Seeking
148 2012.08.13 French,Chris CrisFrangold Lavos/Lidingo ONCS 3InnovativeBiotechStockstoConsiderToday Y N
Alpha

Seeking Isotopes,Shortages,Solutions&TheGrowing
149 2012.08.14 Nichols,Brian N/A Lavos/Lidingo ADMD Y N
Alpha DemandofCancerTreatment

Seeking
150 2012.08.15 Nichols,Brian N/A Lavos/Lidingo IMUC ICT107IntoPerspectivePart1 Y N
Alpha

Seeking GalenaShowingSimilaritiestoImmunogen
151 2012.08.15 Nichols,Brian N/A Lavos/Lidingo GALE Y N
Alpha andLookstoFollowItsPath

Seeking 3BiotechStocksShowingPromisein
152 2012.08.17 French,Chris CrisFrangold Lavos/Lidingo ADMD Y N
Alpha RadiotherapyTreatment

19
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 20 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

BigBottlersCocaColaandPepsiCoBring
Seeking
153 2012.08.17 Lidingo Kawabe,Henry Lavos/Lidingo STVF SteviaFromHealthFoodStoresto Y N
Alpha
Mainstream

Seeking TheFutureLooksSweetforMonsantoasNew
154 2012.08.19 Writer2 N/A Lavos/Lidingo STVF Y N
Alpha OpportunitiesinAgribusinessEmerge

Seeking
155 2012.08.20 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo NBS WeeklyStockWatchforAugust20 Y N
Alpha

3CompanieswithPromisingInvestment
Seeking
156 2012.08.20 Lidingo A.JohnHodge Lavos/Lidingo ADMD PotentialinBrachytherapyTreatmentfor Y N
Alpha
Cancer

Seeking DiggingDeeperintoLessInvasiveCancer
157 2012.08.20 Lidingo Baldwin,Amy Lavos/Lidingo ONCS Y N
Alpha TreatmentInvestments

Seeking CellTherapyOutlookStartingtoMatchClinical
158 2012.08.21 Lidingo TheSwissTrader Lavos/Lidingo NBS Y N
Alpha Results

Seeking WhiteHouseStanceonMedicalIsotopesMay
159 2012.08.22 Lidingo TheSwissTrader Lavos/Lidingo ADMD Y Y
Alpha LeaveForeignProducersNuked

Market CanSteviaFirstCorporation(STVF)CashInon
160 2012.08.22 Lidingo Olsen,Sven Lavos/Lidingo STVF Y N
Playground a$60BillionMarket?

20
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 21 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking ADiverseGroupofPharmaceuticalsWith
161 2012.08.23 Lidingo TheSwissTrader Lavos/Lidingo ONCS Y Y
Alpha GoodUpsidePotential

Seeking AssessingGalenaBiopharma'sStockUpgrade
162 2012.08.24 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha andReflectingonOtherUpgrades

Seeking InvestmentsinSociety'sSweetTooth:Old
163 2012.08.26 Lidingo Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha AndNewIdeas

Seeking
164 2012.08.27 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo ADMD,ONCS WeeklyStockWatch:Weekof27August Y Y
Alpha

Seeking ConsiderTheseThreeBiotechStocksfor
165 2012.08.27 French,Chris MelDaris Lavos/Lidingo NBS Y Y
Alpha PotentialGrowth

Seeking
166 2012.08.29 Lidingo Baldwin,Amy Lavos/Lidingo NBS,ONCS Biotech:MegaCapsShowInvestorstheWay Y Y
Alpha

Seeking 4BiotechStockswithLarge2012Gainsthat
167 2012.08.29 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo GALE Y Y
Alpha StillPresentSignificantUpside

NBS,ONCS, Seeking
168 2012.09.04 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo WeeklyStockWatch:Weekof4September Y Y
ADMD Alpha

21
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 22 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking AGoldMineinBiotechnology:TheCompanies
169 2012.09.04 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo GALE Y Y
Alpha PoisedtoBenefit

Seeking StarbucksAddingSteviatoTheirEnergyDrinks
170 2012.09.05 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y Y
Alpha MaybeaBoostforSteviaGrowers

Seeking
171 2012.09.05 French,Chris CrisFrangold Lavos/Lidingo ADMD DiverseStocksinModernRadiotherapy Y Y
Alpha

Seeking DevelopmentsovertheNextYearthatCould
172 2012.09.05 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo NBS Y Y
Alpha ChangeNeoStem

Seeking AmarinandNeoStem:2CompaniesMaking
173 2012.09.06 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo NBS Y Y
Alpha MajorMovesThisWeek

Seeking
174 2012.09.06 French,Chris CrisFrangold Lavos/Lidingo ONCS 3InvestmentsinTargetedCancerTreatment Y Y
Alpha

Market SugarandSteviaMayBethePerfectBlendfor
175 2012.09.07 Lidingo Kawabe,Henry Lavos/Lidingo STVF Y N
Playground Consumers,CompaniesandInvestors

Seeking StemCellTherapy:TheBlackandWhite
176 2012.09.10 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha TherapiesoftheSpace

22
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 23 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3CompaniesWithExcitingPhaseIITrialData
177 2012.09.10 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y Y
Alpha CloseOut2012

Seeking 3CompaniesWithPromisingGrowthPotential
178 2012.09.10 Lidingo AngNguyen Lavos/Lidingo STVF Y Y
Alpha fromStevia

Seeking CancerTreatmentNeedistheMotherof
179 2012.09.11 Ramey,Stephen Chemistfrog Lavos/Lidingo ADMD,GALE Y Y
Alpha NovelSolutions

IsotopeManufacturingCompaniesStepUpas
Seeking
180 2012.09.17 Corenman,Joel Woods,GlenS. Lavos/Lidingo ADMD AgingNuclearReactorsandGovernment Y Y
Alpha
PoliciesThreatenNuclearMedicine

Seeking Biotechnology:ValuationDoesn'tAlways
181 2012.09.17 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha IndicateValue

Seeking NeoStem:APromisingInvestmentCandidate
182 2012.09.17 Lidingo TheSwissTrader Lavos/Lidingo NBS Y Y
Alpha inStemCellTreatment

Seeking PromisingDevelopmentPhasePharmas
183 2012.09.18 Lidingo A.JohnHodge Lavos/Lidingo GALE,ONCS Y Y
Alpha LeadingtheFightAgainstCancer

Seeking NeuralstemRemindsInvestorsofStemCell
184 2012.09.19 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y Y
Alpha RewardsandRisk

23
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 24 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking MultiStagePharmaceuticalsWithInvestment
185 2012.09.24 Lidingo Kawabe,Henry Lavos/Lidingo GALE Y Y
Alpha PotentialintheWaronCancer

Seeking 3PharmaceuticalsPursuingNonSurgical
186 2012.09.24 Lidingo TheSwissTrader Lavos/Lidingo ONCS Y Y
Alpha ApproachestoCombatingCancer

ThePromising,Cheap,andGrowingCell
Seeking
187 2012.09.24 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo NBS TherapyArenaContinuestoOutperformthe Y Y
Alpha
Market

SteviaFirstCorp.(STVF)FlexesitsMuscles
Market
188 2012.09.26 Lidingo Woods,GlenS. Lavos/Lidingo STVF withTwoMeansforProducingValuableStevia Y N
Playground
Sweetener

Seeking 4SharePriceDipsThatMightOnlyBe
189 2012.09.28 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo NBS Y Y
Alpha Temporary

Seeking
190 2012.10.01 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS InterviewwithOncoSecCEOPunitDhillon Y Y
Alpha

Seeking AssessingPeregrineandSeekingUpsideinthe
191 2012.10.01 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo GALE Y Y
Alpha Space

Seeking PureCircleCouldNeedMoreProductionto
192 2012.10.01 Lidingo(Nichols) TradingMaven Lavos/Lidingo STVF Y Y
Alpha MeetSteviaDemand

24
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 25 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking WatchforShortTermGainsinSharesof
193 2012.10.03 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha Neostem

NYC'sCurbonOversizedSugaryDrinksMay
Market
194 2012.10.04 Lidingo Olsen,Sven Lavos/Lidingo STVF LeadFastFoodOperatorstoFindHealthier Y N
Playground
AlternativestoSugar

Seeking
195 2012.10.05 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo NBS 6StocksonTheMoveThisWeek Y Y
Alpha

Seeking 4BiotechStockswithLarge2012GainsStill
196 2012.10.07 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo GALE Y Y
Alpha PresentSignificantUpsideRevisited

Seeking NeoStem:TheBestUpsideinAnInnovating
197 2012.10.07 Lidingo(Nichols) Kawabe,Henry Lavos/Lidingo NBS Y Y
Alpha Space

Yahoo 2deliverysystemsmakeOncoSecstandout
198 2012.10.08 Lidingo(Nichols) wise4stocks Lavos/Lidingo ONCS Y N
Finance [sic]because...

Seeking HalloweenLikeFearsInfluenceSmallPharma
199 2012.10.09 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y Y
Alpha TradingTechniquesfor4Q2012

Seeking ClinicalDataSeparate3HopefulCancer
200 2012.10.10 Lidingo Kawabe,Henry Lavos/Lidingo GALE Y Y
Alpha Candidates

25
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 26 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 5BiotechCompanieswithMajorMarket
201 2012.10.10 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo NBS,ONCS Y Y
Alpha MovingAnnouncementstoStarttheWeek

Seeking
202 2012.10.11 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo ONCS 5MidWeekStocksOnTheMove Y Y
Alpha

Seeking 3CompaniesthatCouldSoaronMassive
203 2012.10.11 Lidingo AngNguyen Lavos/Lidingo STVF,ADMD Y Y
Alpha SteviaMarketOpportunities

Seeking
204 2012.10.15 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo ONCS WeeklyStockWatch,WeekOf15October Y Y
Alpha

Seeking 3AgricultureStockstoConsiderforExposure
205 2012.10.16 French,Chris MelDaris Lavos/Lidingo STVF Y Y
Alpha toStevia

Seeking NobelPrizeValidatesRecentStemCell
206 2012.10.16 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha Headlines

Seeking
207 2012.10.18 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo GALE,ONCS 5BigTimeBiotechMoversonWednesday Y Y
Alpha

Seeking
208 2012.10.22 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo ONCS WeeklyStockWatchforOctober22,2012 Y Y
Alpha

26
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 27 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking RevisitingtheInvestmentPotentialin
209 2012.10.22 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y Y
Alpha ElectroporationCompanies

Seeking 3CompanieswithPromisingNewCancer
210 2012.10.23 Lidingo TheSwissTrader Lavos/Lidingo GALE Y Y
Alpha Treatments

Seeking PossibleReverseSplitShouldBeTheCatalyst
211 2012.10.23 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo NBS Y Y
Alpha NeededToTakeNeoStemSharesHigher

Seeking InvestorsTakeNote:Dr.OzToutsSteviaas
212 2012.10.24 Lidingo Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha TheBestoftheSugarAlternatives

Seeking
CommentonInvestorsTakeNote:Dr.Oz
213 2012.10.24 Lidingo Chemistfrog Lavos/Lidingo STVF Alpha Y N
ToutsSteviaasBestoftheSugarAlternatives
COMMENT

BeyondTraditionalDrugs:Investmentsin
Seeking
214 2012.10.25 Lidingo A.JohnHodge Lavos/Lidingo NBS,ONCS StemCell,MedicalDevicesandAgent Y Y
Alpha
Administration

Seeking
215 2012.10.29 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo ONCS WeeklyStockWatch,WeekOf29October Y Y
Alpha

Seeking NotSoScaryWatchListforWeekof
216 2012.10.30 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y Y
Alpha Halloween2012

27
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 28 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking InvestmentPotentialInPharmaceuticalCMO
217 2012.10.30 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y Y
Alpha GrowthAcceleration

Seeking RecentResearchandGalena'sNewDataMay
218 2012.10.31 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha LeadtoanAdvanceinStandardsofCare

Seeking RecentBiotechPriceDipsMakeGreatEntries
219 2012.11.01 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha forInvestors

Seeking AfteraDataPackedOctober,WhatWill
220 2012.11.01 Lidingo TheSwissTrader Lavos/Lidingo NBS Y Y
Alpha NovemberbringforNeoStem?

Seeking 3CompanieswithInvestmentPotentialin
221 2012.11.01 Lidingo A.JohnHodge Lavos/Lidingo ADMD Y Y
Alpha TargetingCancer

Seeking
222 2012.11.04 Lidingo TheSwissTrader Lavos/Lidingo ADMD AChangeinSupplytoMeetIsotopeDemand Y Y
Alpha

Seeking InvestmentsIntheFightAgainstCancer:The
223 2012.11.05 Corenman,Joel Woods,GlenS. Lavos/Lidingo GALE Y Y
Alpha AnalystsChoices

Seeking NeoStemCEODr.SmithTalksPCTPotential
224 2012.11.05 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha andExplainsRecentBullishDevelopments

28
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 29 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking MonsterBeveragetoFollowtheLeadof
225 2012.11.05 Lidingo AngNguyen Lavos/Lidingo STVF Y Y
Alpha GreenMountainCoffeeRoasters

Seeking NeostemtoCreateValuewithBillionDollar
226 2012.11.07 Lidingo Baldwin,Amy Lavos/Lidingo NBS Y Y
Alpha Potential

DevelopingSynergisticRelationshipBetween
Seeking
227 2012.11.08 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF SugarManufacturersandSteviaCouldProve Y Y
Alpha
toHaveHighInvestmentPotential

Seeking 3AcquisitionsinBiotechnologythatCould
228 2012.11.11 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha OccurintheNextYear

Seeking GalenaBiopharma:CatalystsHaveLedIts
229 2012.11.12 Corenman,Joel Woods,GlenS. Lavos/Lidingo GALE Y Y
Alpha StockHigher

UpcomingMelanomaConferenceisan
Seeking
230 2012.11.12 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS ExcellentSourceofSmallPharmaInvestor Y Y
Alpha
Information

Seeking
231 2012.11.12 Lidingo A.JohnHodge Lavos/Lidingo ADMD Nordion'sFutureDoesNotLookBright Y Y
Alpha

Seeking
232 2012.11.12 Lidingo TheSwissTrader Lavos/Lidingo NBS AnExcitingWeekinCellTherapy Y Y
Alpha

29
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 30 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
233 2012.11.12 Lidingo TradingMaven Lavos/Lidingo STVF CompaniesSeeGreeninStevia Y N
Alpha

Seeking TheStemCellSectorFurtherValidatesItself
235 2012.11.14 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y Y
Alpha withaSuccessfulQ3

RecentDataPresentedatMelanoma
Seeking
236 2012.11.16 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS ConferenceOffersHopeforPatients,Research Y Y
Alpha
forInvestors

SteviaFirstCorp.(STVF)UtilizingFermentation
Market
237 2012.11.16 Lidingo Kawabe,Henry Lavos/Lidingo STVF TechniquestoProduceHighQualitySteviaata Y N
Playground
LowerCost

Seeking BreakingBarriersinCardiovascular
238 2012.11.19 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo NBS Y Y
Alpha Treatments

Seeking 4SpeculativeInvestmentsYouMightWantto
239 2012.11.19 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo ONCS Y Y
Alpha Consider

Seeking NeoStemAwarded$1.2MillionGrantforVSEL
240 2012.11.21 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo NBS Y Y
Alpha Development

DistinguishingFadfromTrendinGlutenFree
Seeking
241 2012.11.26 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF andSteviaMarketsMayExposeProfitable Y Y
Alpha
InvestmentOpportunities

30
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 31 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3DifficulttoUnderstandTrendsin
242 2012.11.26 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha Biotechnology

NovelImmunotherapyandDeliverySystems
Seeking
243 2012.11.26 Lidingo Kawabe,Henry Lavos/Lidingo ADMD,GALE TargetingCancerMayTargetGainsfor Y Y
Alpha
Investors

Seeking Q32012PharmaCompanyUpdatesIndicate
244 2012.11.27 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y Y
Alpha UpcomingCatalysts

AcadiaPharmaceuticalsandGalena
Seeking
245 2012.11.28 Nichols,Brian N/A Lavos/Lidingo GALE Biopharma:WhataDifferenceaTrialDesign Y Y
Alpha
CanMake

N/A(articledoes ThreeCompanieswithRecentSuccessful
234 2012.11.29 Lidingo(Nichols) notincludeauthor Lavos/Lidingo NBS Benzinga AnimalBasedStudiesCouldIndicateSolid Y N
name) Upside

Seeking SmallMarketCapPharmaceuticalswithLarge
246 2012.11.30 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y Y
Alpha CatalystsLoomingin2013

SteviaGrowersandProcessorsNeedto
Seeking
247 2012.12.03 Lidingo Kawabe,Henry Lavos/Lidingo STVF DevelopforTheFoodIndustrytoReachFull Y Y
Alpha
Potential

Seeking 5StockswiththeCatalystsandOpportunity
248 2012.12.04 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha forLargeReturnsOvertheNextYear

31
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 32 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking TargetedRadiationLookstoCreateandGrow
249 2012.12.05 Lidingo TheSwissTrader Lavos/Lidingo ADMD Y Y
Alpha Revenue

Seeking SmallPharmaSectorLeadersCouldMakea
250 2012.12.06 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y Y
Alpha ProfitableDiversifiedPortfolio

CompaniesAdvancingRadiotherapyIn
Seeking
251 2012.12.10 Lidingo A.JohnHodge Lavos/Lidingo ADMD FightingCancerMayAlsoDeliverStrongGains Y Y
Alpha
forInvestors

CompaniesGearUpasHealthCanada
Seeking
252 2012.12.11 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF ApprovesSteviaasAdditiveforFoodand Y Y
Alpha
BeverageUse

Seeking GalenaBiopharma:RecentDevelopments
253 2012.12.11 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo GALE Y Y
Alpha PaintAPictureOfTheYearAhead

Seeking CelsiontoOpentheDoorforMedicalDevice
254 2012.12.11 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo ONCS Y Y
Alpha CompaniesFollowingItsSuccess

Seeking
255 2012.12.12 Lidingo(Nichols) A.JohnHodge Lavos/Lidingo NBS 5StockstoWatchinBiotech Y Y
Alpha

Seeking AsSteviaGrowsinAcceptance,Companies
256 2012.12.16 Lidingo TradingMaven Lavos/Lidingo STVF Y Y
Alpha andInvestorsMayFindSweetRewards

32
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 33 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking GalenaPullsBackWhileAnalystsRushtoits
257 2012.12.17 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha Defense

Seeking 3SmallPharmaCompanieswithMajor
258 2012.12.17 Ramey,Stephen Chemistfrog Lavos/Lidingo ADMD Y Y
Alpha Catalystsin2013

Market ThreeBiopharmaceuticalCompanieswith
259 2012.12.17 Lidingo(Nichols) Sterling,William Lavos/Lidingo ONCS Y N
Playground AdvancingPromisingSkinCancerTreatments

Seeking
260 2012.12.18 Lidingo(Nichols) TheSwissTrader Lavos/Lidingo GALE GalenaRemovesFinancingRisk Y Y
Alpha

Seeking InvestmentsinNovelIL12Administration
261 2012.12.25 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y Y
Alpha PlatformsintheFightagainstCancer

Seeking 4SmallBiotechStocksThatShouldContinue
262 2012.12.25 Lidingo A.JohnHodge Lavos/Lidingo GALE Y Y
Alpha WithLargeReturnsin2013

Seeking WithOsirisOvervalued,NeoStemIsABetter
263 2013.01.02 Lidingo Baldwin,Amy Lavos/Lidingo NBS Y Y
Alpha Buy

Seeking SuccessfulInfusionofCancerTreatmentMay
264 2013.01.07 Lidingo A.JohnHodge Lavos/Lidingo ONCS Y Y
Alpha AttractInfusionofInvestorsin2013.

33
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 34 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3InvestmentsinStevia/SugarBlendstoMixIn
265 2013.01.07 Lidingo Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha WithYourPortfolio

Seeking 'TopoftheClass'SmallPharmaInvestments
266 2013.01.14 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE,ADMD Y Y
Alpha for2013

Seeking TopoftheClassSmallPharmaInvestmentsfor
267 2013.01.17 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE,NBS Y Y
Alpha 2013PartII

Seeking WhatMakesforaMarketLeadingReturnin
268 2013.01.22 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha Biotechnology?

OncosecMedicalInc.(ONCS)AContinuous
Market
269 2013.01.22 Lidingo(Nichols) Baldwin,Amy Lavos/Lidingo ONCS NewsStreamCouldProducePortfolio Y N
Playground
ChangingGains

Seeking NordionContinuesToPrepareInvestorsForA
270 2013.01.22 Lidingo(Nichols) TeresaDawn Lavos/Lidingo ADMD Y Y
Alpha NewLookCompany

Seeking GrowingUseofRadiopharmaceuticalsfor
271 2013.01.28 Lidingo A.JohnHodge Lavos/Lidingo ADMD Y Y
Alpha FightingCancerShowsPromise

Market SteviaFirst(STVF)AnInvestmentinan
272 2013.01.29 Lidingo LeopoldEpstein Lavos/Lidingo STVF Y N
Playground EmergingBillionDollarBusiness

34
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 35 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Dunedin; Seeking ImminentCatalystsShouldKeepInvestor

273 2013.02.04 Ramey,Stephen Chemistfrog ONCS Y Y
Lavos/Lidingo Alpha InterestAliveForThese3Pharmaceuticals

Seeking InvestinginZeroCalorieSugarSubstitutes
274 2013.02.04 Lidingo AngNguyen Lavos/Lidingo STVF Y Y
Alpha MayFattenInvestors'Wallets

Seeking ExtendingLivesThroughNuclearMedicine
275 2013.02.04 Lidingo TheSwissTrader Lavos/Lidingo ADMD Y Y
Alpha MayAlsoExtendInvestors'Profits

Seeking AComprehensiveLookatImmunotherapy
276 2013.02.08 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha WithImmunologistDr.RahulJasuja

Seeking 3SmallCapRadiopharmaceuticalsWithan
277 2013.02.11 Ramey,Stephen Chemistfrog Lavos/Lidingo ADMD Y Y
Alpha Exciting2013Ahead

Seeking 3CuttingEdgeCancerTherapiesMayTarget
278 2013.02.11 Lidingo Baldwin,Amy Lavos/Lidingo ONCS Y Y
Alpha InvestorPortfoliostoYieldGains

Seeking WhatDoSteviaFirstandArena
279 2013.02.12 Writer1 N/A Lavos/Lidingo STVF Y Y
Alpha PharmaceuticalsHaveinCommon?

Investor
280 2013.02.14 Lidingo TheSwissTrader Lavos/Lidingo ONCS FourSmallBiotechswithBigPotentialin2013 Y N
Village

35
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 36 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking StocksCouldRiseForCompaniesInvestingin
281 2013.02.18 Lidingo Sterling,William Lavos/Lidingo ONCS Y Y
Alpha ImmunotherapyTreatments

Seeking
282 2013.02.18 Lidingo(Nichols) LeopoldEpstein Lavos/Lidingo STVF 4SmallCapsSeeingPositiveReversals Y Y
Alpha

Seeking 3SpeculativeHealthcareCompanieswithHigh
283 2013.02.19 Writer1 N/A Lavos/Lidingo ADMD Y Y
Alpha LevelsofInsiderOwnership

Seeking
284 2013.02.19 Writer5 DutchTrader Lavos/Lidingo GALE Galena:ASmallCapBiotechReadytoFly? Y Y
Alpha

Seeking DiagnosisandTreatmentofDiseasewith
285 2013.02.25 Corenman,Joel Woods,GlenS. Lavos/Lidingo ADMD Y Y
Alpha RadiotherapiesMayProveProfitablein2013

Seeking
286 2013.02.25 Nichols,Brian N/A Lavos/Lidingo GALE TheMondayMorningQuarterback Y Y
Alpha

Seeking 5SpeculativeBiotechStockswithCatalysts
287 2013.02.25 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha Pending

Seeking 2012StemCellStandoutsandtheOutlookfor
288 2013.02.28 Lidingo TheSwissTrader Lavos/Lidingo NBS Y Y
Alpha 2013

36
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 37 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking AComprehensiveLookatImmunotherapy
289 2013.03.04 Nichols,Brian N/A Lavos/Lidingo GALE,ONCS Y Y
Alpha Part2

Seeking 3SpeculativeBiotechCompaniesLookingto
290 2013.03.06 Lidingo A.JohnHodge Lavos/Lidingo ADMD Y Y
Alpha ReshapetheHealthcareLandscape

Seeking SeekingOpportunity:CreatingaPlanof
291 2013.03.08 Nichols,Brian N/A Lavos/Lidingo GALE,NBS Y Y
Alpha InvestmentAction

Seeking TheWeekendBlitz:ADiscussionof
292 2013.03.10 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha InvestmentStrategiesandInvestmentIdeas

Seeking CargillMakesaBigInvestmentintheFuture
293 2013.03.11 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y Y
Alpha ofStevia

Seeking 3UndiscoveredBiotechCompaniesForThe
294 2013.03.11 Lidingo Sterling,William Lavos/Lidingo GALE,NBS Y Y
Alpha HealthcareInvestor

Seeking
295 2013.03.11 Writer5 DutchTrader Lavos/Lidingo ONCS LookingBacktoAlternativeCancerTherapies Y Y
Alpha

Seeking SeekingOpportunity:10StockstoWatch
296 2013.03.15 Nichols,Brian N/A Lavos/Lidingo GALE,NBS Y Y
Alpha RightNow

37
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 38 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3BiotechStocksThatareSetUpNicelyfor
297 2013.03.17 Lidingo A.JohnHodge Lavos/Lidingo NBS Y Y
Alpha Growth

Seeking TheWeekendBlitz:FindingValue,Market
298 2013.03.18 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha Behavior,&DiversificationRelatedPlays

Seeking
299 2013.03.18 Lidingo LeopoldEpstein Lavos/Lidingo STVF NextGenerationofSweetenerMarketPlayers Y Y
Alpha

Seeking 3CompaniesDevelopingNovelCancerDrug
300 2013.03.18 Lidingo Sterling,William Lavos/Lidingo ONCS Y Y
Alpha DeliveryPlatforms

NewRegulationstoPhaseOutHEU
Seeking
301 2013.03.18 Lidingo TheSwissTrader Lavos/Lidingo ADMD RadioisotopesMayPhaseInMoneyfor Y Y
Alpha
Investors

Seeking 3ImmunotherapyCompaniesthatHave
302 2013.03.18 Lidingo TeresaDawn Lavos/Lidingo GALE Y Y
Alpha LearnedTheirLessonsWell

Seeking
303 2013.03.24 Nichols,Brian N/A Lavos/Lidingo GALE TheBlitz:AretheseStocksPresentingUpside? Y Y
Alpha

Seeking 3CompanieswithInnovativeMangement
304 2013.03.25 Lidingo Lassiter,Phil Lavos/Lidingo STVF Y Y
Alpha TeamstoPropelBusinessForward

38
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 39 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking GalenaBiopharma:ASmallCapLookingfor
305 2013.03.25 Writer5 DutchTrader Lavos/Lidingo GALE Y Y
Alpha Revenues

Seeking BiotechnologySuperPanelTalks
306 2013.03.27 Lidingo TheSwissTrader Lavos/Lidingo NBS Y Y
Alpha Development,MarketingandtheFuture

Seeking RecentMelanomaTrialDataHasBiotech
307 2013.03.27 Lidingo TheSwissTrader Lavos/Lidingo ONCS Y Y
Alpha StocksMoving

Seeking The'Blitz':LookingatIndividualStocks
308 2013.03.31 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha PresentingValue

Seeking 3ContendersWithNovel,NonInvasive
309 2013.04.01 Lidingo TheSwissTrader Lavos/Lidingo ONCS Y Y
Alpha TreatmentsforCancer

Seeking GalenaBiopharma:WillDevelopments
310 2013.04.03 Lidingo Baldwin,Amy Lavos/Lidingo GALE Y Y
Alpha ContinueIn2013?

Seeking MedicalIsotopeProducersCouldbeLucrative
311 2013.04.03 Lidingo Lassiter,Phil Lavos/Lidingo ADMD Y Y
Alpha InvestmentVentures

Seeking RetailPharmacyStocksContinuetoRise
312 2013.04.04 Corenman,Joel Woods,GlenS. Lavos/Lidingo APHY Y Y
Alpha DespiteStiffCompetition

39
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 40 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3RadiotherapyCompaniesThatCouldMake
313 2013.04.08 Corenman,Joel Woods,GlenS. Lavos/Lidingo ADMD Y Y
Alpha BigGainsin2013

Seeking The9LevelsofBiotechnologyAndWho
314 2013.04.08 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha ShouldInvest:Part2

Seeking TheVatican/NeostemPartnershipLooksto
315 2013.04.10 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha CreateInterestandAdvanceCellTherapy

Seeking
316 2013.04.11 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo APHY StockWatchThursday,11April2013 Y Y
Alpha

Seeking
317 2013.04.11 Lidingo Baldwin,Amy Lavos/Lidingo ONCS BSDMedicalNewstoCreateaSpark Y Y
Alpha

Seeking SpecialtyPharmacies:AnOverlooked
318 2013.04.15 Corenman,Joel Woods,GlenS. Lavos/Lidingo APHY Y Y
Alpha SegmentinaProfitableIndustry

Seeking 5BiotechnologyStocksThatGreatly
319 2013.04.15 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha OutperformedtheMarketinQ1

Seeking
320 2013.04.15 Lidingo Baldwin,Amy Lavos/Lidingo ONCS 2UndervaluedImmunotherapyPicks Y Y
Alpha

40
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 41 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking HealthcareSectorTrendsMaybeShifting
321 2013.04.16 Cassano,Vincent VFC'sStockHouse Lavos/Lidingo APHY Y Y
Alpha TowardsBoutiquePharmacyServices

Market InterviewwithAdvancedMedicalIsotope
322 2013.04.16 Ramey,Stephen Chemistfrog Lavos/Lidingo ADMD Y N
Playground Corp.(ADMD)CEOJamesKatzaroff

Seeking CompaniesFocusedonCancersofthe
323 2013.04.20 Thornton,Ciaran StockInvestor Lavos/Lidingo ONCS Y Y
Alpha EpidermalLayersMayYieldProfits

Seeking AnIndustryOutlookwithAnalystVernon
324 2013.04.22 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha Bernardino

Market AssuredPharmacyAPossibleNewDrug
325 2013.04.22 Ramey,Stephen Chemistfrog Lavos/Lidingo APHY Y N
Playground AbuseDeterrenceBusinessModel

Seeking DarwinianSelectioninMedicalDevices:
326 2013.04.22 Writer6 EnhydrisPECorp Lavos/Lidingo ADMD Y Y
Alpha BrachytherapyOffersInvestorsHope

Seeking
327 2013.04.23 Lidingo A.JohnHodge Lavos/Lidingo ONCS Melanoma:Battleof3CancerVaccines Y Y
Alpha

Seeking NeoStem:ASimpleLookatRegenerative
328 2013.04.25 Lidingo Sterling,William Lavos/Lidingo NBS Y Y
Alpha Medicine

41
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 42 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking CouldEnzoBiochemsIntellectualProperty
329 2013.04.28 Corenman,Joel Woods,GlenS. Lavos/Lidingo ENZ Y Y
Alpha LawsuitsBeWorthBillions?

Seeking
330 2013.04.28 Nichols,Brian N/A Lavos/Lidingo ONCS 5StocksToWatchForGainsNextWeek Y Y
Alpha

Seeking
331 2013.04.28 Thornton,Ciaran StockInvestor Lavos/Lidingo NBS RegenerativeMedicine'sTimeHasCome Y Y
Alpha

Seeking
332 2013.04.29 Lidingo Kawabe,Henry Lavos/Lidingo STVF ThreeMarketTrendstoWatch Y Y
Alpha

Seeking
333 2013.05.01 Writer5 DutchTrader Lavos/Lidingo APHY LookingIntotheSpecialtyPharmacySector Y Y
Alpha

Seeking ProfitsCanBeFoundintheExpandingand
334 2013.05.03 Lidingo TheSwissTrader Lavos/Lidingo ADMD Y Y
Alpha ChallengingMedicalIsotopeBusiness

Seeking
335 2013.05.04 Nichols,Brian N/A Lavos/Lidingo ONCS 5StocksToWatchforGainsNextWeek Y Y
Alpha

Seeking CompaniesDevelopingTargetedCancer
336 2013.05.06 Lidingo TeresaDawn Lavos/Lidingo ONCS Y Y
Alpha TreatmentsSeekHigherProfitsin2013

42
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 43 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking Generalistvs.SpecialistApproachesinthe
337 2013.05.06 Writer6 EnhydrisPECorp Lavos/Lidingo APHY Y Y
Alpha CompetitivePharmacySpace

Seeking
338 2013.05.11 Nichols,Brian N/A Lavos/Lidingo ONCS,NBS 5StocksToWatchForGainsNextWeek Y Y
Alpha

EnzoBiochem'sIntellectualProperty
Seeking
339 2013.05.13 Ramey,Stephen Chemistfrog Lavos/Lidingo ENZ ProtectionToAttractInvestorAttentionIn Y Y
Alpha
2013

Seeking InvestinginPharmacyStocksCouldBethe
340 2013.05.13 Thornton,Ciaran StockInvestor Lavos/Lidingo APHY Y Y
Alpha NextMajorPlay

Seeking
341 2013.05.14 Meyer,Thomas EquityOptionsGuru Lavos/Lidingo NBS 3BiotechStocksWithPotential Y Y
Alpha

Seeking 3SmallCapCancerStockswithUpcoming
342 2013.05.20 Meyer,Thomas EquityOptionsGuru Lavos/Lidingo ONCS Y Y
Alpha Catalysts

Seeking AFocusonStemCellTherapyand
343 2013.05.20 Lidingo A.JohnHodge Lavos/Lidingo NBS Y Y
Alpha RegenerativeMedicinefor2013

WillSteviaProvideaSweetReturnfor
344 2013.05.20 Writer6 EnhydrisPECorp Lavos/Lidingo STVF MotleyFool Y N
Investors?

43
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 44 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

InvestorsHu ProposedLegislationCompoundsPharmacy
345 2013.05.28 Writer3 N/A Lavos/Lidingo APHY Y N
b Risks

Seeking
346 2013.05.28 Meyer,Thomas EquityOptionsGuru Lavos/Lidingo NBS NeoStemABiotechwithLotsofPromise Y Y
Alpha

Investing.co PharmaceuticalStocksContinueto
347 2013.06.03 Meyer,Thomas JimTaylor Lavos/Lidingo APHY Y N
m Outperform

AsConsumersDemandNatural,SteviaSetto
348 2013.06.05 Writer3 N/A Lavos/Lidingo STVF Minyanville Y N
BecomeBlockbusterProduct

TheBattleofIL12AdministrationforCancer
349 2013.06.06 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Benzinga Y N
Treatment:IsitReallyaBattle?

StockPick:DrugScaresandPharmacySecurity
350 2013.06.10 Writer3 N/A Lavos/Lidingo APHY Minyanville Y N
CreateOpportunityforSmallPlayer

Market CanSteviaHelpSoftDrinksGetPastthe
351 2013.06.11 Keolanui,Craig N/A Lavos/Lidingo STVF Y N
Playground ObesityandDiabetesEpidemic?

Seeking Oncosec'sandZiopharm'sIL12Targeted
352 2013.06.12 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Y Y
Alpha DeliverySystems:WhichWillSucceed?

44
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 45 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Immunotherapy:FourCompaniesonthe
353 2013.06.17 Meyer,Thomas T.M.Meyer Lavos/Lidingo ONCS Minyanville Y N
VergeofCancerTreatmentBreakthroughs

Seeking
354 2013.06.28 Nichols,Brian N/A Lavos/Lidingo NBS 5MeaningfulUpgradesThatYouShouldNote Y Y
Alpha

NeoStemInc.:AStemCellCompanywithan
355 2013.07.01 Meyer,Thomas T.M.Meyer Lavos/Lidingo NBS Minyanville Y N
AttractiveValuation

InvestorsHu
356 2013.07.08 Writer3 N/A Lavos/Lidingo STVF NewSteviaExtractsWhatstheReb? Y N
b

Seeking AnOverlookedMetricinBiotechnologyThat
357 2013.07.09 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha YouShouldUtilize

Seeking Finally!ElectroporationIsBeingNoticedBy
358 2013.07.11 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha TheStreet

Seeking WhatDoesThisReverseSplitMeanFor
359 2013.07.12 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha NeostemShareholders?

SteviaFirstCorpSettoBecomeLeaderinNon
360 2013.07.15 Meyer,Thomas T.M.Meyer Lavos/Lidingo STVF Minyanville Y N
CaloricBeverageIndustry

45
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 46 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 5SpeculativeBiotechStocksWithCatalysts
361 2013.07.17 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha Pending:Revisited

Seeking NeoStemAnnouncesSeveralKeyMilestones
362 2013.07.22 Meyer,Thomas EquityOptionsGuru Lavos/Lidingo NBS Y Y
Alpha ThatShouldExciteInvestors

Seeking NeostemGreatReverseSplitActivity,But
363 2013.07.25 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha What'sNext?

NewAnalyticToolsFuelGrowthinPersonal
364 2013.07.26 Writer3 N/A Lavos/Lidingo ONCS Minyanville Y N
Medicine

BiotechStocksContinuetoSeeSharePrices
365 2013.07.30 Meyer,Thomas T.M.Meyer Lavos/Lidingo ONCS Minyanville Y N
JumponCatalysts

Seeking GreatLeadershipandMassiveOpportunities
366 2013.07.30 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha MakeThisHireTerrific

BiotechStocks:BreastCancerDrugsinClinical
367 2013.08.01 Meyer,Thomas T.M.Meyer Lavos/Lidingo GALE Minyanville Y N
TrialsOfferNewHope

CocaColaandPepsi:FacingSlowerSales,Big
368 2013.08.05 Writer3 N/A Lavos/Lidingo STVF Minyanville Y N
SodaisTestingSteviainSampleMarkets

46
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 47 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking NeoStem:AStemCellLeaderMakingAllthe
369 2013.08.05 Keolanui,Craig N/A Lavos/Lidingo NBS Y Y
Alpha RightMoves

Seeking NeoStem'sAthelosCouldBeginGarnering
370 2013.08.13 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y Y
Alpha Attention

Seeking 2BiotechsAimToCapitalizeontheTreatment
371 2013.08.13 Lidingo Baldwin,Amy Lavos/Lidingo ONCS Y Y
Alpha ofMelanoma

Seeking GalenaBiopharma:BestandWorstCase
372 2013.08.14 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha Scenario

Seeking
373 2013.08.18 Lidingo TheSwissTrader Lavos/Lidingo NBS CouldBaxterAcquireThisSmallCompany? Y Y
Alpha

CocaCola'sGambleonCokeLifeMayhave
Seeking
374 2013.08.19 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF OtherBottlersScramblingforaBetterTasting Y Y
Alpha
Stevia

Seeking WithVicalOut,What'sNextForThe
375 2013.08.19 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha MelanomaPipeline?

Seeking SeekingtheBestOpportunitiesinBiotechby
376 2013.08.20 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha Value

47
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 48 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
377 2013.08.22 Writer5 DutchTrader Lavos/Lidingo GALE GalenaBiopharma,ReadyforAJump? Y Y
Alpha

SmallCapNe ImmunotherapyBroadensHopeforPatients
378 2013.08.29 Writer3 AlphaVNSecurities Lavos/Lidingo ONCS Y N
twork andInvestors

WallStreet 4ReasonsNeoStemMaySeeSignificantShare
379 2013.09.03 Meyer,Thomas N/A Lavos/Lidingo NBS Y N
CheatSheet PriceAppreciation

Seeking CocaColaMakesSeriousChangesToStayOn
380 2013.09.03 Lidingo/Hodge Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha Top

Seeking
381 2013.09.04 Lidingo/Hodge A.JohnHodge Lavos/Lidingo ONCS 4BiotechswithCatalystsLooming Y Y
Alpha

Seeking 3BiotechProductstoWatchOvertheNext
382 2013.09.04 Lidingo/Hodge Baldwin,Amy Lavos/Lidingo GALE Y Y
Alpha Year

Seeking NeoStemAndNeuralstem:2Early
383 2013.09.08 Thornton,Ciaran StockInvestor Lavos/Lidingo NBS Y Y
Alpha RegenerativeMedicineWinners

WallStreet 2SmallCapBiotechnologyStockswithBig
384 2013.09.11 Meyer,Thomas N/A Lavos/Lidingo GALE Y N
CheatSheet Promise

48
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 49 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking
385 2013.09.11 Lidingo TeresaDawn Lavos/Lidingo GALE Inovio'sPartnershipanditsManyBenefits Y Y
Alpha

Market
386 2013.09.12 Nichols,Brian ArthurRhodes Lavos/Lidingo ONCS OncoSec:APresentationofCatalysts Y N
Playground

NovartisandNeoStem:DevelopingTherapies
Seeking
387 2013.09.12 Corenman,Joel Woods,GlenS. Lavos/Lidingo NBS toExtendtheQualityofLifeforHeartDisease Y Y
Alpha
Patients

SmallCapNe ImmunotherapiesExtendEffectivenessof
388 2013.09.16 Writer3 AlphaVNSecurities Lavos/Lidingo GALE Y N
twork StandardCare

NewMethodofProducingSteviaMay
SmallCapNe
389 2013.09.16 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF ChallengetheEntire$10BillionSugar Y N
twork
SubstituteMarket

Seeking NeostemContinuesToSoarBehindASlewOf
390 2013.09.16 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha KeyDevelopments

Thestreet.c
391 2013.09.19 Meyer,Thomas N/A Lavos/Lidingo NBS NeoStemToReachItsRealValueByYearEnd Y N
om

Seeking 3CompaniesOnTheForefrontOfCancer
392 2013.09.24 Corenman,Joel Woods,GlenS. Lavos/Lidingo GALE Y Y
Alpha ImmunotherapyInnovations

49
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 50 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking CocaCola'sMovetoStevia:Don'tRush...But
393 2013.09.25 Lidingo Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha MoveQuickly

Seeking 3CompaniesDevelopingtheFutureofCancer
394 2013.09.27 Lidingo/Hodge TheSwissTrader Lavos/Lidingo LBIO Y Y
Alpha Therapy

Seeking
395 2013.09.29 Writer5 DutchTrader Lavos/Lidingo GALE GalenaBiopharma:WhatNow? Y Y
Alpha

Seeking NeoStem:AnInvestmentIn4Different
396 2013.09.30 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha Divisions

WallStreet 3SmallCapBiotechnologyStocksMakingBig
397 2013.10.01 Meyer,Thomas N/A Lavos/Lidingo ONCS Y N
CheatSheet Moves

Seeking InvestingSmart:Biotechs,EffectiveTherapies
398 2013.10.02 Nichols,Brian N/A Lavos/Lidingo LBIO Y Y
Alpha andShareholderFriendlyCEOs

Seeking CompaniesRacetoDeveloptheNextNovel
399 2013.10.06 Corenman,Joel Woods,GlenS. Lavos/Lidingo NBS Y Y
Alpha BlockbusterDiabetesDrugPart2

Seeking CelebratingBreastCancerAwarenessWithA
400 2013.10.06 Lidingo/Hodge Baldwin,Amy Lavos/Lidingo GALE Y Y
Alpha GreatYearofClinicalBreakthroughs

50
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 51 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

OncoSecMedicaltoWrapUp2013with
401 2013.10.07 Ramey,Stephen Chemistfrog Lavos/Lidingo ONCS Benzinga Y N
MultiplePossibleCatalysts

Seeking 4CompaniesYouMustWatchRegardlessof
402 2013.10.09 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha MarketPerformance

WallStreet
403 2013.10.15 Meyer,Thomas JamesRatz Lavos/Lidingo STVF ThreeCompaniesFightingtoStopObesity Y N
CheatSheet

Seeking ThisShortTermPainMightbeBestforLong
404 2013.10.15 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha TermGain

Seeking WillLostPatentsForceRocheintoAcquisition
405 2013.10.15 Thornton,Ciaran StockInvestor Lavos/Lidingo GALE Y Y
Alpha Mode?

Seeking 5CompaniesRaceToDevelopTheNextGreat
406 2013.10.18 Lidingo TheSwissTrader Lavos/Lidingo LBIO Y Y
Alpha MelanomaProduct

SmallCapNe
407 2013.10.21 Writer3 AlphaVNSecurities Lavos/Lidingo ONCS NewBroadStepsForwardinCancerDrugs Y N
twork

Seeking CelgeneandNeostem:2Biopharmaceutical
408 2013.10.21 Lidingo A.JohnHodge Lavos/Lidingo NBS Y Y
Alpha CompaniesPoisedforGrowth

51
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 52 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

DoLowExpectationsSettheStageforLarge
409 2013.10.22 Nichols,Brian N/A Lavos/Lidingo GALE MotleyFool Y N
PostLaunchGains

Seeking Coke'sFutureRemainsUncertain,WhilePepsi
410 2013.10.22 Lidingo Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha ContinuestoThrive

WallStreet
411 2013.10.28 Meyer,Thomas N/A Lavos/Lidingo ONCS FourBiotechStocksMakingHeadlines Y N
CheatSheet

Seeking InvestmentsinTargetingHER2forthe
412 2013.10.28 Ramey,Stephen Chemistfrog Lavos/Lidingo GALE Y Y
Alpha TreatmentofCancer

ExaminingHealthierOptionsinOurDietsand
413 2013.10.28 Thornton,Ciaran BuySellShort Lavos/Lidingo STVF Benzinga Y N
Investments

Seeking Biotechnology:FindingtheBestandWorst
414 2013.10.30 Nichols,Brian N/A Lavos/Lidingo GALE Y Y
Alpha ValueintheIndustry

Seeking NeoStem:MajorDevelopmentsYouMight
415 2013.10.30 Lidingo/Hodge TheSwissTrader Lavos/Lidingo NBS Y Y
Alpha HaveMissed

Seeking
Alpha SinghSecuresLionfor2Years&Preparesfor
416 2013.10.31 Nichols,Brian N/A Lavos/Lidingo LBIO Y N
Instablog Uplisting
SubSite

52
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 53 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 5ShortTermCatalystsMakeGalenaaLong
417 2013.11.02 Lidingo A.JohnHodge Lavos/Lidingo GALE Y Y
Alpha TermBuy

SmallCapNe Millennials:TheDrivingForceBehindStevias
418 2013.11.04 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y N
twork Growth?

WallStreet ThreePromisingBiotechStockswith
419 2013.11.04 Meyer,Thomas N/A Lavos/Lidingo NBS Y N
CheatSheet UpcomingCatalysts

SmallCapNe AnInvestmentinBiotech:Searchingforthe
420 2013.11.05 Thornton,Ciaran StockInvestor Lavos/Lidingo ONCS Y N
twork NextBigCancerPlay

HastheNextInsysTherapeuticsBeen
421 2013.11.07 Nichols,Brian N/A Lavos/Lidingo GALE MotleyFool Y N
Identified?

Seeking InvestinginCompaniesTargetingMillennials
422 2013.11.12 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y Y
Alpha ShouldProveProfitable

WallStreet
423 2013.11.12 Meyer,Thomas JamesRatz Lavos/Lidingo GALE WillGalenaBiopharmaTripleSoon? Y N
CheatSheet

Seeking CombinationTherapiesHoldKeyToFuture
424 2013.11.12 Nichols,Brian N/A Lavos/Lidingo LBIO Y Y
Alpha CancerTreatments

53
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 54 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking ExcitingStemCellInvestmentCandidatesWith
425 2013.11.12 Ramey,Stephen Chemistfrog Lavos/Lidingo NBS Y Y
Alpha NearTermCatalysts

Seeking TreatingMelanoma:OnlyTheBestShall
426 2013.11.13 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha Survive

WallStreet 3BiotechnologyStocksintheCancerSpace
427 2013.11.14 Meyer,Thomas N/A Lavos/Lidingo LBIO Y N
CheatSheet withStrongGrowthPotential

SmallCapNe InvestinginCompaniesDevelopingPromising
428 2013.11.18 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y N
twork ImmunotherapyDrugsforMelanoma

WallStreet SteviaFirstSurgesinAnticipationof
429 2013.11.18 Meyer,Thomas JamesRatz Lavos/Lidingo STVF Y N
CheatSheet CommercialLaunch

WallStreet PositiveTrialDataSendsGalenaBiopharma
430 2013.11.22 Meyer,Thomas MattLevy Lavos/Lidingo GALE Y N
CheatSheet SharesHigher

Seeking CompaniesAdvancingStemCellTherapies
431 2013.11.25 Corenman,Joel Woods,GlenS. Lavos/Lidingo NBS Y Y
Alpha CouldAlsoAdvanceYourPortfolioDollars

WallStreet OncosecMedicalLeadingtheChargeAgainst
432 2013.11.25 Meyer,Thomas N/A Lavos/Lidingo ONCS Y N
CheatSheet SkinCancer

54
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 55 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking LionBiotechnologies:3BullishReasonsWhyI
433 2013.11.25 Nichols,Brian N/A Lavos/Lidingo LBIO Y Y
Alpha LikethisSpeculativeBiotech

Seeking S&WSeedCompany:AvoidingWhatShould
434 2013.11.25 Lidingo/Hodge Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha BeItsMainFocus

Seeking
435 2013.11.27 Writer4 StockWhisper Lavos/Lidingo GALE Galena:MoreReasonstoBuy Y Y
Alpha

Seeking MedicalDeviceCompanieswithBigGrowth
436 2013.12.01 Lidingo/Hodge Lassiter,Phil Lavos/Lidingo ARTH Y Y
Alpha Potential

WallStreet 3HealthyFoodsCompaniesthatWillMake
437 2013.12.02 Meyer,Thomas MattLevy Lavos/Lidingo STVF Y N
CheatSheet yourPortfolioGreen

WallStreet 2BiotechStocksFacingMajorCatalystsin
438 2013.12.02 Meyer,Thomas N/A Lavos/Lidingo LBIO Y N
CheatSheet 2014

Seeking
439 2013.12.02 Thornton,Ciaran StockInvestor Lavos/Lidingo GALE Galena:APipelineRichforInvestors Y Y
Alpha

Seeking FightingBackagainsttheGrowingThreatof
440 2013.12.02 Thornton,Ciaran StockInvestor Lavos/Lidingo ONCS Y Y
Alpha Melanoma

55
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 56 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 4CompaniesDevelopingBlockbuster
441 2013.12.09 Corenman,Joel Woods,GlenS. Lavos/Lidingo LBIO Y Y
Alpha ImmunotherapiestoFightCancer

SmallCapNe
442 2013.12.09 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF SteviaFirstCorp.GearsUpforSalesin2014 Y N
twork

WallStreet NeoStem:AStemCellCompanyWorth
443 2013.12.09 Meyer,Thomas N/A Lavos/Lidingo NBS Y N
CheatSheet Watching

InvestmentFundsareTakingaBigStakein
444 2013.12.10 Meyer,Thomas TedMayer Lavos/Lidingo GALE MotleyFool Y N
GalenaBiopharma

Seeking 3BreastCancerDrugsThatCouldBoostYour
445 2013.12.11 Lidingo Baldwin,Amy Lavos/Lidingo GALE Y Y
Alpha Portfolio

Seeking CokeLifesPossibleU.S.DebutShouldBolster
446 2013.12.15 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y Y
Alpha CocaColaandSteviaSales

Seeking
Alpha ArchTherapeutics,APromisingNewLife
447 2013.12.16 Writer5 DutchTrader Lavos/Lidingo ARTH Y Y
Instablog ScienceCompany
SubSite

SmallCapNe ArchTherapeutics,APromisingNewLife
448 2013.12.16 Writer5 DutchTrader Lavos/Lidingo ARTH Y N
twork ScienceCompany

56
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 57 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

HopeforBreastCancerPatientsisAroundthe
449 2013.12.16 Meyer,Thomas N/A Lavos/Lidingo GALE Forbes.com Y N
Corner

WallStreet
450 2013.12.17 Meyer,Thomas MattLevy Lavos/Lidingo NBS NeoStem:FinalDataisJustAroundtheCorner Y N
CheatSheet

Seeking TheRacetoTreatStageIIIMelanomaJustGot
451 2013.12.17 Nichols,Brian N/A Lavos/Lidingo ONCS Y Y
Alpha aLotMoreInteresting

Seeking WhyisCompleteEnrollmentImportantto
452 2013.12.17 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha NeostemInvestors?

Seeking
453 2013.12.19 Nichols,Brian N/A Lavos/Lidingo GALE WillGalena'sPostHolidayCharmContinue? Y Y
Alpha

Seeking 4StocksIn4IndustriesThatCouldMake
454 2013.12.23 Nichols,Brian N/A Lavos/Lidingo LBIO Y Y
Alpha SignificantGainsIn2014

Seeking
Alpha MelanomaBiotechPlayertoConsider:
455 2013.12.23 Thornton,Ciaran StockInvestor Lavos/Lidingo ONCS Y N
Instablog OncoSecMedical(instablog)
SubSite

Seeking NeoStemStandsToBenefitFromStemCell
456 2013.12.23 Thornton,Ciaran StockInvestor Lavos/Lidingo NBS Y Y
Alpha Deals

57
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 58 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

WallStreet
457 2013.12.30 Meyer,Thomas N/A Lavos/Lidingo ONCS OncoSecMedicalPoisedforExciting2014 Y N
CheatSheet

SmallCapNe
458 2013.12.30 Thornton,Ciaran Itradethebios Lavos/Lidingo ARTH ARevolutionaryBloodLossProduct Y N
twork

SmallCapNe InvestinginCompaniesSweeteningtheMid
459 2013.12.30 Lidingo EliasHertz Lavos/Lidingo STVF Y N
twork CalorieBeverageMarket

Seeking CellularTherapy:RepresentingParadigmShift
460 2013.12.31 Writer4 StockWhisper Lavos/Lidingo NBS Y Y
Alpha inHealthcare

Seeking 4StocksthatCouldSeeSignificantGainsin
461 2014.01.06 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha 2014

Seeking IsBarron'sRightOrWronginPredicting20%
462 2014.01.06 Lidingo/Hodge Kawabe,Henry Lavos/Lidingo STVF Y Y
Alpha UpsideinCoke?

SmallCapNe
463 2014.01.07 Thornton,Ciaran Itradethebios Lavos/Lidingo ARTH HemostasisProductsANewGrowthMarket Y N
twork

Seeking 4CompaniesThatShouldProfitFrom
464 2014.01.13 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y Y
Alpha ConsumerHealthTrendsin2014

58
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 59 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking UniqueTreatmentApproachesComingfor
465 2014.01.13 Meyer,Thomas Kingmaker Lavos/Lidingo ONCS Y Y
Alpha SkinCancer

WallStreet TwoInnovativeBiotechCompaniesthatCould
466 2014.01.13 Meyer,Thomas JamesRatz Lavos/Lidingo NBS Y N
CheatSheet Soarin2014

WallStreet BuyingOpportunityinOncoSecMedicalas
468 2014.01.14 Meyer,Thomas N/A Lavos/Lidingo GALE Y N
CheatSheet CatalystsApproach

WallStreet TheMomentumContinuesforGalena
469 2014.01.15 Meyer,Thomas ChristineAndrews Lavos/Lidingo GALE Y N
CheatSheet Biopharma

Seeking AreModifiedTCellsAGameChangerin
470 2014.01.15 Lidingo/Hodge TheSwissTrader Lavos/Lidingo LBIO Y Y
Alpha TreatingCancer?

SmallCapNe
471 2014.01.20 Writer5 DutchTrader Lavos/Lidingo ARTH ArchTherapeutics,WheretoGoFromHere? Y N
twork

Seeking
Alpha
472 2014.01.20 Writer5 DutchTrader Lavos/Lidingo ARTH ArchTherapeutics,WheretoGoFromHere? Y N
Instablog
SubSite

SmallCapNe InsysTherapeuticsARoadMapforGalena
473 2014.01.20 Thornton,Ciaran StockInvestor Lavos/Lidingo GALE Y N
twork Biopharmain2014

59
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 60 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 3SmallBiotechCompaniesPoisedforBig
474 2014.01.21 Corenman,Joel Woods,GlenS. Lavos/Lidingo NBS Y Y
Alpha Growthin2014

WallStreet
475 2014.01.21 Nichols,Brian N/A Lavos/Lidingo ONCS Electroporation:LookingAheadat2014 Y N
CheatSheet

WallStreet NeoStem'sAMR001HasStrongChanceof
476 2014.01.22 Meyer,Thomas JamesRatz Lavos/Lidingo NBS Y N
CheatSheet Success

Seeking InvestinginCompaniesthatWillProfitfrom
477 2014.01.27 Corenman,Joel Woods,GlenS. Lavos/Lidingo STVF Y Y
Alpha theGrowingHealthierFoodMarket

Seeking
479 2014.01.27 Nichols,Brian N/A Lavos/Lidingo NBS CouldPCTBeNeostem'sBreakoutStar? Y Y
Alpha

OncosecExecutivesTalkElectroporation,PD1
Seeking
480 2014.01.29 Nichols,Brian N/A Lavos/Lidingo ONCS CheckpointInhibitors,andtheUnmetNeedIn Y Y
Alpha
ImmuneOncology

Seeking ContractManufacturing:OftenIgnored,but
481 2014.02.03 Thornton,Ciaran StockInvestor Lavos/Lidingo NBS Y Y
Alpha PotentiallyProfitable

Seeking CombinationTherapies:WhereImmuno
482 2014.02.06 Nichols,Brian N/A Lavos/Lidingo LBIO Y Y
Alpha OncologyIsHeadedAndHowToInvest

60
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 61 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

Seeking 2Young'Cats'ofBiotechPoisedtoClimb
483 2014.02.10 Corenman,Joel Woods,GlenS. Lavos/Lidingo LBIO Y Y
Alpha Higherin2014

Seeking IsThereInvestmentUpsideintheFutureof
484 2014.02.10 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha TreatingDiabetes?

SmallCapNe FindingPossibleInvestmentCandidatesat
485 2014.02.11 Thornton,Ciaran Itradethebios Lavos/Lidingo ARTH Y N
twork EquityConferences

WallStreet BigPharmaContinuestheRacefor
486 2014.02.17 Nichols,Brian N/A Lavos/Lidingo ONCS Y N
CheatSheet Electroporation

WallStreet
487 2014.02.18 Meyer,Thomas JohnRivers Lavos/Lidingo NBS ImmuneCheckpointBlockerRaceHeatsUp Y N
CheatSheet

WallStreet ThreeGreatSmallCapBiotechStocks:
488 2014.02.18 Meyer,Thomas JohnRivers Lavos/Lidingo GALE Y N
CheatSheet Neostem,Pozen,Curis

Seeking 2CellTherapyCompaniesthatCouldThrive
489 2014.02.24 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha withCardiovascularDisease

Seeking ModifiedTCells:QuietlyBecomingVery
490 2014.03.01 Nichols,Brian N/A Lavos/Lidingo LBIO Y Y
Alpha Relevant

61
 Case 1:17-cv-02540 Document 1-1 Filed 04/10/17 Page 62 of 62
AppendixA

ADMD=AdvancedMedicalIsotopeCorporation;AMPE=AmpioPharmaceuticals,Inc.;APHY=AssuredPharmacy,Inc.(nowbankrupt);ARTH=ArchTherapeutics,Inc.;ENZ=EnzoBiochem,Inc.;GALE=GalenaBiopharma,Inc.;IMUC=
ImmunocellularTechnologies,Ltd.;LBIO=LionBiotechnologies,Inc.;LPTN=LPath,Inc.(nowAPEN;ApolloEndosurgery,Inc.);NBS=Neostem,Inc.(nowCLBS;CaldriusBioscences,Inc.);ONCS=OncosecMedical,Inc.;STVF=SteviaFirst
Corporation(nowVBIO;VitalityBiopharma,Inc.)

Omissionre: Affirmative
Website
Receiptof Misrep.re:
# Date Writer/Publisher Pseudonym Promoter IssuerClient Where Title
Payment Receiptof
Published
(Y/N) Payment(Y/N)

WallStreet NeoStem:aPotentialBlockbusterfor
491 2014.03.03 Meyer,Thomas JamesRatz Lavos/Lidingo NBS Y N
CheatSheet Investors

Seeking ArchTherapeuticsandtheAdvanceWound
492 2014.03.10 Writer5 DutchTrader Lavos/Lidingo ARTH Y Y
Alpha Market

Seeking ZeiherStudyLikelyPredictstheOutcomeof
493 2014.03.10 Nichols,Brian N/A Lavos/Lidingo NBS Y Y
Alpha Neostem'sAMR001Trial

Seeking
494 2014.03.10 Nichols,Brian N/A Lavos/Lidingo ONCS IsOncoSecMedicalSettoTradeEvenHigher? Y Y
Alpha

62